Shares of Reckitt Benckiser Group plc (OTCMKTS:RBGLY - Get Free Report) have received an average recommendation of "Buy" from the eight brokerages that are presently covering the company, Marketbeat reports. Three research analysts have rated the stock with a hold rating, two have assigned a buy rating and three have issued a strong buy rating on the company.
Several equities research analysts have recently weighed in on the stock. Royal Bank of Canada reissued an "outperform" rating on shares of Reckitt Benckiser Group in a research note on Friday, March 7th. Barclays cut Reckitt Benckiser Group from an "overweight" rating to an "equal weight" rating in a research note on Tuesday, February 4th.
Check Out Our Latest Analysis on RBGLY
Reckitt Benckiser Group Stock Performance
Shares of OTCMKTS RBGLY traded up $0.20 during trading on Friday, hitting $12.95. 389,164 shares of the company traded hands, compared to its average volume of 355,946. The company has a debt-to-equity ratio of 0.97, a current ratio of 0.69 and a quick ratio of 0.47. The business's fifty day moving average is $13.27 and its 200 day moving average is $12.66. Reckitt Benckiser Group has a fifty-two week low of $10.24 and a fifty-two week high of $14.10.
Reckitt Benckiser Group Increases Dividend
The firm also recently declared a dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 11th will be issued a $0.2909 dividend. The ex-dividend date of this dividend is Friday, April 11th. This is an increase from Reckitt Benckiser Group's previous dividend of $0.19.
About Reckitt Benckiser Group
(
Get Free ReportReckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Read More
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
